IHEiShares U.S. Pharmaceuticals ETF

Grow my money20y track recordRanked #479 of 2,960 in this goal

Seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

By iShares · Launched 2006

Annual Cost

0.38%

#1,874 of 5,562 · low cost

Fund Size

$913M

#1,162 of 5,562 · large

Return (1Y)Goal

+42.6%

Track Record

20 years

#290 of 5,562 · established

Performance

Total-return NAV · USD

Growth of $10,000

$14,399+44.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Pharmaceuticals

Index tracked

Dow Jones US Select Pharmaceuticals Index

What it actually holds

By weight

Concentration

Top 10 holdings = 78.1% of fundconcentrated

ELI LILLY AND COMPANY

23.8%

JOHNSON & JOHNSON

22.0%

MERCK & CO., INC.

4.7%

ZOETIS INC.

4.7%

BRISTOL-MYERS SQUIBB COMPANY

4.6%

PFIZER INC.

4.2%

ROYALTY PHARMA PLC

3.9%

VIATRIS INC.

3.9%

BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares

3.1%

ELANCO ANIMAL HEALTH INCORPORATED

3.0%

Asset allocation

Stocks

99.6%

Cash

0.3%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

17.2%Moderate

Year-on-year price swings

Max drawdown

-29.6%Moderate

Worst peak-to-trough loss

Sharpe (3Y)

0.86Decent risk-adjusted returns

Sortino (3Y)

1.26Good downside protection

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Strategy: Invests primarily in the Dow Jones U.S. Select Pharmaceuticals Index, which measures the performance of U.S. pharmaceutical companies. Uses representative sampling to manage the Fund, investing at least 80% of assets in the index's component securities.
Inception date: May 1, 2006
Fund family: iShares